Jasmina I Ivanova (Jasmina Ivanova)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Glycemic Control

Chronic Myeloid Leukemia

Top Venues

Prostate cancer and prostatic diseases

Future oncology (London, England)

Diabetes, metabolic syndrome and obesity : targets and therapy

Revista da Associacao Medica Brasileira (1992)

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen J Freedland, Wei Gao, Angela Lax, Hongbo Yang, Krishnan Ramaswamy, David Russell, Agnes Hong, Jasmina I Ivanova
Real-world outcomes following biochemical recurrence after definitive therapy with a short prostate-specific antigen doubling time: potential role of early secondary treatment. Prostate cancer and prostatic diseases (2024)
Daniel J George, Krishnan Ramaswamy, Hongbo Yang, Qing Liu, Adina Zhang, Alexandra Greatsinger, Jasmina I Ivanova, Betty Thompson, Birol Emir, Agnes Hong, Stephen J Freedland
Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Stephen J Freedland, Matthew Davis, Andrew J Epstein, Bhakti Arondekar, Jasmina I Ivanova
Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population. Prostate cancer and prostatic diseases (2023)
Samaneh Kalirai, Jasmina I Ivanova, Magaly Perez-Nieves, Judith J Stephenson, Irene Hadjiyianni, Michael Grabner, Roy Daniel Pollom, Caroline Geremakis, Beverly L Reed, Lawrence Fisher
Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States. Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020)
MeganS Farris, Kelly A Larkin-Kaiser, Tayler D Scory, Devon Boyne, Keith D Wilner, Malaïka Pastel, Joseph Christopher Cappelleri, Jasmina I Ivanova
Network meta analysis of first-line therapy for advanced EGFR mutation positive non-small-cell lung cancer: updated overall survival. Future oncology (London, England) 16 (36) (2020)
Kazuhiko Nakagawa, Koichi Matsumura, Tayler D Scory, Megan S Farris, Kelly A Larkin-Kaiser, Hironori Kikkawa, Jasmina I Ivanova, Keith D Wilner
Indirect analysis of first-line therapy for advanced non-small-cell lung cancer with activating mutations in a Japanese population. Future oncology (London, England) 17 (1) (2020)
Denise Reis Franco, Magaly Perez-Nieves, Jasmina I Ivanova, Dachuang Cao, Marcela Saturnino Caselato Vaz
Basal insulin persistence in Brazilian participants with T2DM. Revista da Associacao Medica Brasileira (1992) 65 (10) (2019)